Sonoma Pharmaceuticals, Inc. (SNOA)
1.21
-0.02
(-1.63%)
USD |
NASDAQ |
Oct 07, 16:00
1.19
-0.02
(-1.65%)
After-Hours: 20:00
Sonoma Pharmaceuticals Profit Margin (Quarterly) : -5.15% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.15% |
| March 31, 2026 | -10.45% |
| December 31, 2025 | -18.83% |
| September 30, 2025 | -9.53% |
| June 30, 2025 | -30.91% |
| March 31, 2025 | -20.67% |
| December 31, 2024 | -26.04% |
| September 30, 2024 | -17.04% |
| June 30, 2024 | -33.71% |
| March 31, 2024 | -31.03% |
| December 31, 2023 | -27.60% |
| September 30, 2023 | -54.34% |
| June 30, 2023 | -41.38% |
| March 31, 2023 | -43.40% |
| December 31, 2022 | -65.86% |
| September 30, 2022 | -30.53% |
| June 30, 2022 | -22.27% |
| March 31, 2022 | -128.1% |
| December 31, 2021 | -32.53% |
| September 30, 2021 | -2.67% |
| June 30, 2021 | -29.80% |
| March 31, 2021 | -159.1% |
| December 31, 2020 | -12.68% |
| September 30, 2020 | 2.62% |
| June 30, 2020 | -12.29% |
| Date | Value |
|---|---|
| March 31, 2020 | -40.56% |
| December 31, 2019 | -27.53% |
| September 30, 2019 | -27.25% |
| June 30, 2019 | 14.99% |
| March 31, 2019 | -73.53% |
| December 31, 2018 | -43.52% |
| September 30, 2018 | -57.10% |
| June 30, 2018 | -79.15% |
| March 31, 2018 | -130.3% |
| December 31, 2017 | -65.81% |
| September 30, 2017 | -66.36% |
| June 30, 2017 | -91.47% |
| March 31, 2017 | -72.70% |
| December 31, 2016 | 22.70% |
| September 30, 2016 | -94.32% |
| June 30, 2016 | -120.8% |
| March 31, 2016 | -82.44% |
| December 31, 2015 | -82.43% |
| September 30, 2015 | -43.49% |
| June 30, 2015 | -63.59% |
| March 31, 2015 | -37.74% |
| December 31, 2014 | -183.8% |
| September 30, 2014 | -22.00% |
| June 30, 2014 | -2.06% |
| March 31, 2014 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
| Johnson & Johnson | 21.86% |
| Eli Lilly & Co. | 30.88% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -54.00% |
| Return on Assets | -15.25% |
| Return on Invested Capital | -46.37% |
| Gross Profit Margin (Quarterly) | 40.23% |
| Operating Margin (Quarterly) | -0.62% |
| Return on Net Operating Assets | -28.63% |